PCN21 TREATMENT COMPARISONS IN PATIENTS WITH UNRESECTABLE HEPTOCELLULAR CARCINOMA (HCC) WHO ARE INELIGIBLE FOR TRANSARTERIAL CHEMOEMBOLISATION (TACE)
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.218
https://www.valueinhealthjournal.com/article/S1098-3015(19)32596-3/fulltext
Title :
PCN21 TREATMENT COMPARISONS IN PATIENTS WITH UNRESECTABLE HEPTOCELLULAR CARCINOMA (HCC) WHO ARE INELIGIBLE FOR TRANSARTERIAL CHEMOEMBOLISATION (TACE)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)32596-3&doi=10.1016/j.jval.2019.09.218
First page :
Section Title :
Open access? :
No
Section Order :
10165